Education
About Us
Working with TipRanks
Follow Us
Seshadri Neervannan Insider Profile
4 Followers
Seshadri Neervannan, COO at Tarsus Pharmaceuticals, holds 79.66K shares in Tarsus Pharmaceuticals (Ticker: TARS).
Seshadri Neervannan Tarsus Pharmaceuticals (TARS)COO
Tarsus Pharmaceuticals (TARS)
COO
Ranked #101,800 out of 105,219 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-133.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Seshadri Neervannan's holdings
Insider Roles
COO
Roles that Seshadri Neervannan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Seshadri Neervannan
Seshadri Neervannan's Trading History
List of latest transactions for each holding click on a transaction to see Seshadri Neervannan's performance on stock
You May Also Like
Seshadri Neervannan insider profile FAQ
What is the percentage of profitable transactions made by Seshadri Neervannan?
The percentage of profitable transactions made by Seshadri Neervannan is 0%.
What is the average return per transaction made by Seshadri Neervannan?
The average return per transaction made by Seshadri Neervannan is -133.50%.
What stocks does Seshadri Neervannan hold?
Seshadri Neervannan holds: TARS stocks.
What was Seshadri Neervannan’s latest transaction?
Seshadri Neervannan latest transaction was an Uninformative Sell of ―.
What was Seshadri Neervannan's most profitable transaction?
Seshadri Neervannan’s most profitable transaction was an Informative Sell of TARS stock on March 20, 2025. The return on the trade was -62.90%.
What is Seshadri Neervannan's role in Tarsus Pharmaceuticals?
Seshadri Neervannan's role in Tarsus Pharmaceuticals is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.